Literature DB >> 2180748

Immunosuppression supports implantation of zona pellucida dissected human embryos.

J Cohen1, H Malter, C Elsner, H Kort, J Massey, M P Mayer.   

Abstract

The effect of low dose immunosuppression with methylprednisolone during the first 4 days after oocyte retrieval on potential immune cell invasion of partially zona dissected embryos in utero was investigated in alternate in vitro fertilization patients (n = 32). The incidence of pregnancy was significantly higher in patients receiving methylprednisolone (7 of 18, 39%) than in control patients (1 of 14, 7%). Twenty-eight percent (11 of 39) of the embryos replaced in the corticosteroid treated patients implanted, whereas only 7% (2 of 31) of embryos in control patients had a fetal heart beat. There were no side effects reported in any of the patients receiving corticosteroids. It can be concluded that methylprednisolone supports implantation of embryos with small holes in their zonae. However, the actual mechanisms of corticosteroid support on the interaction between immune cells and micromanipulated embryos are not well understood.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2180748     DOI: 10.1016/s0015-0282(16)53460-8

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  11 in total

Review 1.  Assisted hatching of human embryos.

Authors:  J Cohen
Journal:  J In Vitro Fert Embryo Transf       Date:  1991-08

Review 2.  Implementing PGD/PGD-A in IVF clinics: considerations for the best laboratory approach and management.

Authors:  Antonio Capalbo; Valeria Romanelli; Danilo Cimadomo; Laura Girardi; Marta Stoppa; Lisa Dovere; Domenico Dell'Edera; Filippo Maria Ubaldi; Laura Rienzi
Journal:  J Assist Reprod Genet       Date:  2016-07-16       Impact factor: 3.412

3.  Dexamethasone as an adjuvant therapy for anovulatory, normoandrogenic patients during ovulation induction with exogenous gonadotropins.

Authors:  D Bider; Y Menashe; M Goldenberg; M Dulitzky; A Lifshitz; J Dor
Journal:  J Assist Reprod Genet       Date:  1996-09       Impact factor: 3.412

4.  Successful glucocorticoid treatment for patients with abnormal autoimmunity on in vitro fertilization and embryo transfer.

Authors:  T Ando; N Suganuma; M Furuhashi; Y Asada; I Kondo; Y Tomoda
Journal:  J Assist Reprod Genet       Date:  1996-11       Impact factor: 3.412

5.  Corticosteroids in patients with antiovarian antibodies undergoing in vitro fertilization: a prospective pilot study.

Authors:  Thierry Forges; Patricia Monnier-Barbarino; Frédérique Guillet-May; Gilbert C Faure; Marie-Christine Béné
Journal:  Eur J Clin Pharmacol       Date:  2006-07-18       Impact factor: 2.953

Review 6.  Peri-implantation glucocorticoid administration for assisted reproductive technology cycles.

Authors:  Carolien M Boomsma; Mohan S Kamath; Stephen D Keay; Nick S Macklon
Journal:  Cochrane Database Syst Rev       Date:  2022-06-30

7.  Assisted hatching reduces the age-related decline in IVF outcome in women younger than age 43 without increasing miscarriage or monozygotic twinning.

Authors:  D R Meldrum; A Wisot; B Yee; G Garzo; L Yeo; F Hamilton
Journal:  J Assist Reprod Genet       Date:  1998-08       Impact factor: 3.412

8.  Chemical removal of the outside of the zona pellucida of day 3 human embryos has no impact on implantation rate.

Authors:  M J Tucker; N M Luecke; S R Wiker; G Wright
Journal:  J Assist Reprod Genet       Date:  1993-04       Impact factor: 3.412

9.  Does addition of low-dose aspirin and/or steroid as a standard treatment in nonselected intracytoplasmic sperm injection cycles improve in vitro fertilization success? A randomized, prospective, placebo-controlled study.

Authors:  Candan Iltemir Duvan; Batuhan Ozmen; Hakan Satiroglu; Cem Somer Atabekoglu; Bulent Berker
Journal:  J Assist Reprod Genet       Date:  2006-03-04       Impact factor: 3.412

Review 10.  The Impact of Biopsy on Human Embryo Developmental Potential during Preimplantation Genetic Diagnosis.

Authors:  Danilo Cimadomo; Antonio Capalbo; Filippo Maria Ubaldi; Catello Scarica; Antonio Palagiano; Rita Canipari; Laura Rienzi
Journal:  Biomed Res Int       Date:  2016-01-28       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.